Anterios IPO Research Information

Anterios IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Anterios, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Anterios	ANTE - NASDAQ	$12.00-$14.00	$0.00	$0.00	3.9 million
Underwriter(s): Stifel, RBC Capital Markets
Co-Manager(s): JMP Securities, Needham & Company
Industry:
Filing(s): Filed 2015-04-01 Terms Added 2015-04-27

About Anterios (adapted from Anterios prospectus):
They are a clinical stage biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum products for therapeutic and aesthetic applications.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ANTE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.